The influence of lactoferrin, orally administered, on systemic iron homeostasis in pregnant women suffering of iron deficiency and iron deficiency anaemia

Biochimie

Volumn 91, Issue 1, 2009, Pages 44-51

  Paesano, Rosalba ^a   Pietropaoli, Miriam ^b   Gessani, Sandra ^c   Valenti, Piera ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Microbo srl Biotechnology Company   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Anaemia; Hypoferremia; Iron; Lactoferrin; Pregnancy

Indexed keywords

FERROUS SULFATE; IRON; LACTOFERRIN;

CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DRUG MECHANISM; GASTROINTESTINAL SYMPTOM; HOMEOSTASIS; HUMAN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; NAUSEA; PREGNANCY; REVIEW; VOMITING;

ADMINISTRATION, ORAL; ANEMIA, IRON-DEFICIENCY; FEMALE; HOMEOSTASIS; HUMANS; IRON; LACTOFERRIN; PREGNANCY;

MAMMALIA;

EID: 58149105930     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2008.06.004     Document Type: Review

References (49)

1. Bullen J.J., Rogers H.J., Spalding P.B., and Ward C.G. Iron and infection: the heart of the matter. FEMS Immunol. Med. Microbiol. 43 (2005) 325-330
2. Valenti P., and Antonini G. Lactoferrin: an important host defence against microbial and viral attack. Cell Mol. Life Sci. 62 (2005) 2576-2587
3. Ganz T., and Nemeth E. Regulation of iron acquisition and iron distribution in mammals. Biochim. Biophys. Acta. 1763 (2006) 690-699
4. Bothwell T.H. Iron requirements in pregnancy and strategies to meet them, Am. J. Clin. Nutr. 72 (2000) 257-264
5. Aisen P. Transferrin receptor 1. Int. J. Biochem. Cell. Biol. 36 (2004) 2137-3
6. Mackenzie B., and Garrick M.D. Iron imports: II. Iron uptake at the apical membrane in the intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) G981-G986
7. Theil E.C. Ferritin: at the crossroads of iron and oxygen metabolism. J. Nutr. 133 (2003) 1549-1553
8. Hentze M.W., Muckenthaler M.U., and Andrews N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 117 (2004) 285-297
9. Casey J.L., Hentze M.W., Koeller D.M., Caughman S.W., Rouault T.A., Klausner R.D., and Harford J.B. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science 240 (1988) 924-928
10. Leibold E.A., and Munro H.N. Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5′ untranslated region of ferritin heavy- and light-subunit mRNAs. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 2171-2175
11. Mullner E.W., and Kuhn L.C. A stem-loop in the 3′ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53 (1988) 815-825
12. Andrews N.C. Molecular control of iron metabolism. Best. Pract. Res. Clin. Haematol. 18 (2005) 159-169
13. De Domenico I., Ward M.D., and Kaplan J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat. Rev. Mol. Cell Biol. 9 1 (2008) 72-81
14. Donovan A., Lima C.A., Pinkus J.L., Pinkus G.S., Zon L.I., Robine S., and Andrews N.C. The iron exporter ferroportin Slc40a1 is essential for iron homeostasis. Cell Metab 1 (2005) 191-200
15. Liu X.B., Yang F., and Haile D.J. Functional consequences of ferroportin 1 mutations. Blood Cells Mol. Dis. 35 (2005) 33-46
16. De Domenico I., Ward D.M., Musci G., and Kaplan J. Evidence for the multimeric structure of ferroportin. Blood 109 (2007) 2205-2209
17. Osaki S., Johnson D.A., and Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241 (1966) 2746-2751
18. Roeser H.P., Lee G.R., Nacht S., and Cartwright G.E. The role of ceruloplasmin in iron metabolism. J. Clin. Invest. 49 (1970) 2408-2417
19. Harris Z.L., Klomp L.W., and Gitlin J.D. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am. J. Clin. Nutr. 67 (1998) 972S-977S
20. Park C.H., Valore E.V., Waring A.J., and Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276 (2001) 7806-7810
21. Krause A., Neitz S., Magert H.J., Schulz A., Forssmann W.G., Schulz-Knappe P., and Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 480 (2000) 147-150
22. Hunter H.N., Fulton D.B., Ganz T., and Vogel H.J. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J. Biol. Chem. 277 (2002) 37597-37603
23. Loreal O., Haziza-Pigeon C., Troadec M.B., Detivaud L., Turlin B., Courselaud B., Ilyin G., and Brissot P. Hepcidin in iron metabolism. Curr. Protein Pept. Sci. 6 (2005) 279-291
24. Ganz T. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract. Res. Clin. Haematol. 18 (2005) 171-182
25. De Domenico I., Ward D.M., Langelier C., Vaughn M.B., Nemeth E., Sundquist W.I., Ganz T., Musci G., and Kaplan J. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol. Biol. Cell 18 (2007) 2569-2578
26. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
27. Nicolas G., Bennoun M., Porteu A., Mativet S., Beaumont C., Grandchamp B., Sirito M., Sawadogo M., Kahn A., and Vaulont S. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl Acad. Sci. U.S.A. 99 (2002) 4596-4601
28. Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Wolfsdorf J.I., and Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100 (2002) 3776-3781
29. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., Beaumont C., Kahn A., and Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110 (2002) 1037-1044
30. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., and Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113 (2004) 1271-1276
31. De Domenico I., Ward D.M., di Patti M.C., Jeong S.Y., David S., Musci G., and Kaplan J. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 26 (2007) 2823-2831
32. Frazer D.M., Wilkins S.J., Becker E.M., Murphy T.L., Vulpe C.D., McKie A.T., and Anderson G.J. A rapid decrease in the expression of DMT1 and Dcytb but not Ireg1 or hephaestin explains the mucosal block phenomenon of iron absorption. Gut. 52 (2003) 340-346
33. Nemeth E., Preza G.C., Jung C.L., Kaplan J., Waring A.J., and Ganz T. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 107 (2006) 328-333
34. Nemeth E., and Ganz T. Regulation of iron metabolism by hepcidin. Annu. Rev. Nutr. 26 (2006) 323-342
35. School T.O. Iron status during pregnancy: setting the stage for mother and infant. Am. J. Clin. Nutr. 81 (2005) 1218-1222
36. Harris E.D. New insights into placental iron transport. Nutr. Rev. 50 (1992) 329-331
37. Cheng Y., Zak O., Aisen P., Harrison S.C., and Walz T. Structure of the human transferrin receptor-transferrin complex. Cell 116 (2004) 565-576
38. Bradley J., Leibold E.A., Harris Z.L., Wobken J.D., Clarke S., Zumbrennen K.B., Eisenstein R.S., and Georgieff M.K. Influence of gestational age and fetal iron status on IRP activity and iron transporter protein expression in third-trimester human placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R894-R901
39. Bastin J., Drakesmith H., Rees M., Sargent I., and Townsend A. Localisation of proteins of iron metabolism in the human placenta and liver. Br. J. Haematol. 134 (2006) 532-543
40. Raghupathy R., Makhseed M., Azizieh F., Omu A., Gupta M., and Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum. Reprod 15 (2000) 713-718
41. Peter Takacs M.D., Kermic L., Green B.S., Athip N., and Scott W. Kauma Richmond V., Increased vascular endothelial cell production of interleukin-6 in severe preeclampsia. Am. J. Obstet. Gynecol. 188 (2003) 741-744
42. Schümann K., Ettle T., Szegner B., Elsenhans B., and Solomons N.W. On risks and benefits of iron supplementation recommendations for iron intake revisited. J. Trace Elem. Med. Biol. 21 (2007) 147-168
43. Makrides M., Crowther C.A., Gibson R.A., Gibson R.S., and Skeaff C.M. Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am. J. Clin. Nutr. 78 (2003) 145-153
44. Baker E.N., and Baker H.M. Molecular structure, binding properties and dynamics of lactoferrin. Cell. Mol. Life Sci. 62 (2005) 2531-2539
45. Berlutti F., Schippa S., Morea C., Sarli S., Perfetto B., Donnarumma G., and Valenti P. Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninasive Escherichia coli strains. Biochem. Cell Biol. 4 (2006) 351-357
46. Paesano R., Torcia F., Berlutti F., Pacifici E., Ebano V., Moscarini M., and Valenti P. Oral administration of lactoferrin increases hemoglobin and total serum iron in pregnant women. Biochem. Cell Biol. 84 (2006) 377-380
47. Lonnerdal B., and Bryant A. Absorption of iron from recombinant human lactoferrin in young US women. Am. J. Clin. Nutr. 83 (2006) 305-309
48. Hadley K.B., Johnson L.K., and Hunt J.R. Iron absorption by healthy women is not associated with either serum or urinary prohepcidin. Am. J. Clin. Nutr. 84 1 (2006) 150-155
49. Jacober M.L., Mamoni R.L., Lima C.S., Dos Anjos B.L., and Grotto H.Z. Anaemia in patients with cancer: role of inflammatory activity on iron metabolism and severity of anaemia. Med. Oncol. 24 3 (2007) 323-329